These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 8215278

  • 1. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [Abstract] [Full Text] [Related]

  • 2. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2471-6. PubMed ID: 7840591
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
    Appelbaum PC, Spangler SK, Jacobs MR.
    J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
    [Abstract] [Full Text] [Related]

  • 4. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [Abstract] [Full Text] [Related]

  • 5. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
    Spangler SK, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():23-7. PubMed ID: 9222066
    [Abstract] [Full Text] [Related]

  • 6. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
    Venezia RA, Yocum DM, Robbiano EM, Echols RM.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1858-61. PubMed ID: 2178340
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of Bay Y3118 against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA, García-Sánchez JE, Trujillano-Martín I, García-Sánchez E, García-García MI, Fresnadillo-Martínez MJ.
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [Abstract] [Full Text] [Related]

  • 10. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, Legaria C, Rollet R, Rossetti A, Predari SC, Castello L.
    Rev Argent Microbiol; 2004 Jun; 36(3):130-5. PubMed ID: 15559195
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [Abstract] [Full Text] [Related]

  • 12. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
    Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
    [Abstract] [Full Text] [Related]

  • 13. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 14. [In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].
    Derriennic M, Reynaud A, Launay C, Courtieu AL.
    Presse Med; 1986 Dec 20; 15(46):2279-81. PubMed ID: 2949268
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1993 Aug 20; 12(8):640-2. PubMed ID: 8223667
    [Abstract] [Full Text] [Related]

  • 16. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B, Naden M.
    J Antimicrob Chemother; 1989 Sep 20; 24 Suppl A():119-24. PubMed ID: 2808203
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY, Ng LS, Kwang LL, Rao S, Eng LC.
    Anaerobe; 2017 Feb 20; 43():69-74. PubMed ID: 27890724
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE.
    Clin Infect Dis; 1996 Dec 20; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [Abstract] [Full Text] [Related]

  • 19. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL, Ednie LM, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1999 Aug 20; 43(8):2027-31. PubMed ID: 10428930
    [Abstract] [Full Text] [Related]

  • 20. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L, Derriennic M, Reynaud A, Devos J, Romond C, Courtieu A.
    Pathol Biol (Paris); 1985 Nov 20; 33(9):899-903. PubMed ID: 3909082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.